|
13 Nov 2007 |
AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
|
|
12 Nov 2007 |
Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting
|
|
09 Nov 2007 |
Promising clinical results from new HIV vaccine
|
|
07 Nov 2007 |
Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
|
|
07 Nov 2007 |
Sanofi Pasteur initiates phase II trial of cell
|
|
06 Nov 2007 |
Presentation of phase IIa results for Cytos Biotechnology’s hypertension vaccine at the American Heart Association Scientific Sessions 2007
|
|
06 Nov 2007 |
GlobeImmune Announces Presentation of Results from a Randomized Phase 1b Study of the GI-5005 Tarmogen in Patients with Chronic Hepatitis C Infection
|
|
05 Nov 2007 |
Curalogic updates from its Phase III clinical study with the ragweed product
|
|
03 Nov 2007 |
IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
|
|
03 Nov 2007 |
IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
|
|
02 Nov 2007 |
Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
|
|
24 Oct 2007 |
Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
|
|
19 Oct 2007 |
Sanofi Pasteur receives FDA approval of meningococcal vaccine for children
|
|
18 Oct 2007 |
Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV
|
|
11 Oct 2007 |
Pharmexa provides update on the development of GV1001
|
|
09 Oct 2007 |
Amorfix Life Sciences develops two vaccines that extend life in Amyotrophic Lateral Sclerosis (ALS) animal model
|
|
02 Oct 2007 |
U.S. Food & Drug Administration approves CSL influenza virus vaccine, for marketing in the U.S.
|
|
28 Sep 2007 |
Phylogica signs asthma research agreement
|
|
26 Sep 2007 |
immatics launches Phase 2 study on cancer vaccine IMA901
|
|
26 Sep 2007 |
VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine
|
|
26 Sep 2007 |
Twinstrand Therapeutics Inc. Files IND Application For Immunogen in Ricin Antidote Study
|
|
22 Sep 2007 |
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate
|
|
20 Sep 2007 |
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
|
|
20 Sep 2007 |
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
|
|
19 Sep 2007 |
Iomai Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study
|
